Antithrombin III in patients with severe sepsis - A multinational, double-blind, randomized, placebo-controlled phase-III study.

被引：0
|
作者：
Opal, S
Heinrichs, H
Mescheder, A
Keinecke, HO
Knaub, S
机构：
[1] Brown Univ, Mem Hosp Rhode Isl, Pawtucket, RI 02860 USA
[2] Centeon Pharma GMBH, Marburg, Germany
来源：
BLOOD | 1998年 / 92卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3444
引用
收藏
页码：108B / 108B
页数：1
相关论文
共 50 条
  • [21] Evaluation of Miglustat Treatment in Patients with Type III Mucopolysaccharidosis: A Randomized, Double-Blind, Placebo-Controlled Study
    Guffon, Nathalie
    Bin-Dorel, Sylvie
    Decullier, Evelyne
    Paillet, Carole
    Guitton, Jerome
    Fouilhoux, Alain
    JOURNAL OF PEDIATRICS, 2011, 159 (05): : 838 - U182
  • [22] Antithrombin III (ATIII) replacement therapy in patients with sepsis and/or postsurgical complications: a controlled double-blind, randomized, multicenter study
    Baudo, F
    Caimi, TM
    de Cataldo, F
    Ravizza, A
    Arlati, S
    Casella, G
    Carugo, D
    Palareti, G
    Legnani, C
    Ridolfi, L
    Rossi, R
    D'Angelo, A
    Crippa, L
    Giudici, D
    Gallioli, G
    Wolfler, A
    Calori, G
    INTENSIVE CARE MEDICINE, 1998, 24 (04) : 336 - 342
  • [23] Antithrombin III (ATILL) replacement therapy in patients with sepsis and/or postsurgical complications: a controlled double-blind, randomized, multicenter study
    F. Baudo
    T. M. Caimi
    F. deCataldo
    A. Ravizza
    S. Arlati
    G. Casella
    D. Carugo
    G. Palareti
    C. Legnani
    L. Ridolfi
    R. Rossi
    A. D’Angelo
    L. Crippa
    D. Giudici
    G. Gallioli
    A. Wolfler
    G. Calori
    Intensive Care Medicine, 1998, 24 : 336 - 342
  • [24] Effect of pentoxifylline in severe sepsis - Results of a randomized, double-blind, placebo-controlled study - Discussion
    Lowry, SF
    Marshall, JC
    ARCHIVES OF SURGERY, 1998, 133 (01) : 100 - 100
  • [25] Double-blind, randomized, placebo-controlled phase III trial of oxymetholone for the treatment of HIV wasting
    Hengge, UR
    Stocks, K
    Wiehler, H
    Faulkner, S
    Esser, S
    Lorenz, C
    Jentzen, W
    Hengge, D
    Goos, M
    Dudley, RE
    Gham, GR
    AIDS, 2003, 17 (05) : 699 - 710
  • [26] An International, Randomized, Double-blind, Placebo-controlled, Phase III Trial of Pregabalin Monotherapy in Treatment of Patients with Fibromyalgia
    Pauer, Lynne
    Winkelmann, Andreas
    Arsenault, Pierre
    Jespersen, Anders
    Whelan, Laurence
    Atkinson, Gary
    Leon, Teresa
    Zeiher, Bernhardt
    JOURNAL OF RHEUMATOLOGY, 2011, 38 (12) : 2643 - 2652
  • [27] Pharmacokinetics and pharmacodynamics of ISA247 in a Phase III, randomized, multicenter, double-blind, placebo-controlled study
    Wasel, N
    Gupta, A
    Tomi, Z
    Papp, K
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2006, 54 (03) : AB9 - AB9
  • [28] Phase III study of apatinib in advanced gastric cancer: A randomized, double-blind, placebo-controlled trial.
    Qin, Shukui
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [29] Tadalafil therapy in pulmonary arterial hypertension: results of a randomized, double-blind, placebo-controlled, phase III study
    Galie, N.
    Brundage, B. H.
    Ghofrani, A.
    Oudiz, R. J.
    Simonneau, G.
    Beardsworth, A.
    Chan, M.
    Barst, R. J.
    EUROPEAN HEART JOURNAL, 2008, 29 : 519 - 519
  • [30] Prevention of irinotecan-induced diarrhea by probiotics: Randomized double-blind, placebo-controlled phase III study
    Mego, Michal
    Chovanec, Jozef
    Andrezalova, Iveta
    Konkolovsky, Peter
    Mikulova, Milada
    Reckova, Maria
    Miskovska, Vera
    Bystricky, Branislav
    Medvecova, Lenka
    Mikusova, Dagmar
    Lagin, Adela
    Svetlovska, Daniela
    Spanik, Stanislav
    Mardiak, Jozef
    Zajac, Vladimir
    Drgona, Lubos
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
12345